Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001415889-11-001079
Filing Date
2011-10-04
Accepted
2011-10-03 17:35:29
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 fluoropharma10qajune302011.htm 10-Q/A 747836
2 ex31-1.htm EX-31.1 16206
3 ex32-1.htm EX-32.1 5812
  Complete submission text file 0001415889-11-001079.txt   2221409

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fpmi-20110630.xml EX-101.INS 238575
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fpmi-20110630_cal.xml EX-101.CAL 30642
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fpmi-20110630_def.xml EX-101.DEF 8147
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE fpmi-20110630_lab.xml EX-101.LAB 98238
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fpmi-20110630_pre.xml EX-101.PRE 72201
9 XBRL TAXONOMY EXTENSION SCHEMA fpmi-20110630.xsd EX-101.SCH 19498
Mailing Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116 (617) 482-2333 X122
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

EIN.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 333-147193 | Film No.: 111121139
SIC: 4950 Sanitary Services